arrow
I

Ilias Alevizos

j amgen inc., thousand oaks, ca, usa
H指数:36
被引数:6,084

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DAZODALIBEP (ANTI-CD40L) EFFECTIVELY REDUCES MULTIPLE PROTEINS ASSOCIATED WITH B-, T-, AND DENDRITIC CELL BIOMARKERS IN SJOGREN'S DISEASE: CORROBORATION OF IMMUNOPHENOTYPING FINDINGS FROM THE ALISS PHASE 2 STUDY

DAZODALIBEP(抗CD40L)有效降低舍格伦综合征中与B细胞、T细胞和树突状细胞生物标志物相关的多种蛋白质:对ALISS II期研究结果中免疫表型发现的佐证

2024-06-010
PRE
Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells (vol 13, 4287, 2022)

全基因组关联研究确定Sjogren的风险位点与免疫和腺细胞的功能意义 (卷13,4287,2022)

2022-10-314
OAAI
Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells

全基因组关联研究确定了Sjogren的风险位点,在免疫和腺细胞中具有功能意义

2022-07-2749
OAAI
Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot
2018-09-0132
OAAI
Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjogren's Syndrome
2017-10-1236
OAAI